Molecular detection of pneumocystis jirovecii in patients with respiratory tract infections

North American Journal of Medical Sciences

Volumn 4, Issue 10, 2012, Pages 479-485

  Terry Alli, Oyebode Armstrong ^a   Ogbolu, David Olusoga ^a   Ademola, Olufunmi ^a   Oyenike, Musiliu Adewale ^a  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Molecular identification; Nigeria; Pneumocystis jirovecii (carinii); Polymerase chain reaction

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUNGAL DETECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPUTUM EXAMINATION;

EID: 84867487523     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.101993     Document Type: Article

References (31)

1. Ypma-Wong MF, Fonzi WA, Sypherd PS. Fungus-specific translation elongation factor 3 gene present in Pneumocystis carinii. Infect Immun 1992;60:4140-4145.
2. Cushion MT, Harmsen A, Matsumoto Y, Stringer JR, Wakefield AE, Yamada M. Recent advances in the biology of Pneumocystis carinii. J Med Vet Mycol 1994;32(Suppl 1):217-228.
3. Mills J. Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis 1986;8:1001-1011.
4. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med 1974;80:83-93.
5. Huang L, Morris A, Limper AH, Beck JM; ATS Pneumocystis Workshop Participants. An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP). Proc Am Thorac Soc 2006;3:655-664.
6. Koziel H, Li X, Armstrong MY, Richards FF, Rose RM. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am J Respir Cell Mol Biol 2000;23:452-459.
7. Thomas CH, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-2498.
8. Wright TW, Gigliotti F, Finkelstein JN, McBride JT, An CL, Harmsen AG. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 1999;104:1307-1317.
9. Hay JW, Osmond DH, Jacobson MA. Projecting the medical costs of AIDS and ARC in the United States. J Acquir Immune Defic Syndr 1988;1:466-485.
10. Weverling GJ, Mocroft A, Ledergerber B, Kirk O, Gonzales-Lahoz J, d'Arminio Monforte A, et al. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group. Lancet 1999;353:1293-1298.
11. Worodria W, Okot-Nwang M, Yoo SD, Aisu T. Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum acid fast bacilli smear-negative. Int J Tuberc Lung Dis 2003;7:117-123.
12. Wakefield AE, Stewart TJ, Moxon ER, Marsh K, Hopkin JM. Infection with Pneumocystis carinii is prevalent in healthy Gambian children. Trans R Soc Trop Med Hyg 1990;84:800-802.
13. Cheesbrough M. District Laboratory Practice in Tropical Countries Part 2. 1st ed. Cambridge: Cambridge University Press; 2000.
14. Nakamura Y. PCR Detection of Pneumocystis carinii: Diagnosis and therapeutic monitoring. In: Persing D, Smith T, Tenover F, White T, editors. Diagnostic Molecular Microbiology: Principles and applications. Washington, D.C.: ASM; 1993. p. 437-440.
15. Fishman JA. Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother 1998;42:995-1004.
16. Kitada K, Oka S, Kimura S, Shimada K, Serikawa T, Yamada J, et al. Detection of Pneumocystis carinii sequences by polymerase chain reaction: Animal models and clinical application to noninvasive specimens. J Clin Microbiol 1991;29:1985-1990.
17. Sing A, Trebesius K, Roggenkamp A, Russmann H, Tybus K, Pfaff F, et al. Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 2000;38:1461-1467.
18. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999;354:1347-1351.
19. Rabodonirina M, Raffenot D, Cotte L, Boibieux A, Mayencon M, Bayle G, et al. Rapid etection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: Use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol 1997;35:2748-2751.
20. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990;336:451-453.
21. Guidelines for prophylaxis of Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991;40(RR-2):1-13.
22. Dini L, du Plessis M, Frean J, Fernandez V. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol 2010;48:2016-2021.
23. Selik RM, Starcher ET, Curran JW. Opportunistic diseases reported in AIDS patients: Frequencies, associations, and trends. AIDS 1987;1:175-182.
24. Aderaye G, Bruchfeld J, Olsson M, Lindquist L. Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia. AIDS 2003;17:435-440.
25. Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 2008;46:625-633.
26. Sing A, Roggenkamp A, Autenrieth IB, Heesemann J. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol 1999;37:3409-3410.
27. Probst M, Ries H, Schmidt-Wieland T, Serr A. Detection of Pneumocystis carinii DNA in patients with chronic lung diseases. Eur J Clin Microbiol Infect Dis 2000;19:644-645.
28. Morris A, Sciurba FC, Norris KA. Pneumocystis: A novel pathogen in chronic obstructive pulmonary disease? COPD 2008;5:43-51.
29. Petty TL. Scope of the COPD problem in North America: Early studies of prevalence and NHANES III data: Basis for early identification and intervention. Chest 2000;117:326S-3231S.
30. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998;4:1241-1243.
31. Malin AS, Gwanzura LK, Klein S, Robertson VJ, Musvaire P, Mason PR. Pneumocystis carinii pneumonia in Zimbabwe. Lancet 1995;346:1258-1261